In the recent years, mounting evidence has also revealed MEG3’s connection to type 2 diabetes and insulin resistance in the pancreas [34], diabetic microvascular dysfunction [35], and nephropathy [36]. This evidence concerns the gene MEG3 and type 2 diabetes mellitus.